Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.
The effects of n3 polyunsaturated fatty acids (PUFA) on cardiovascular disease are controversial. We currently explored the effects of various ratios of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on high fat induced atherosclerosis. In model apoE( mice, high fat diets (HFD) were partially replaced with fish and algal oils (DHA/EPA 2:1, 1:1 and 1:2) and/or plant oils enriched in linoleic and alpha linolenic acids with an n6/n3 ratio of 4:1. PUFA supplementation significantly reduced the atherosclerotic plaque area, serum lipid profile, inflammatory response, aortic ROS production, proinflammatory factors and scavenger receptor expression as compared to those in the HFD group. However, plant oils did not have a significant effect on the following: serum HDL C level; aortic ABCA1, ABCG1 and LAL mRNA expression; and CD36 and LOX 1 protein expression. Compared to the plant oil treated group, the DHA/EPA 1:1 group had a smaller atherosclerotic plaque area, higher serum HDL C levels and lesser CD36 and MSR 1 mRNA expression; the DHA/EPA 2:1 group had lower serum TC, LDL C and TNF a levels and lower aortic ROS levels. Our study suggested that n3 PUFA from animals had more potent atheroprotective effects than that from plants. Supplementation involving higher DHA/EPA ratios and an n6/n3 ratio of 4:1 was beneficial for reducing serum "bad cholesterol" and a 1:1 DHA/EPA ratio with an n6/n3 ratio of 4:1 was beneficial for improving serum "good cholesterol" and inhibiting ox LDL uptake. Our results suggest that achieving an n6/n3 ratio of 4:1 in the diet is also important in addition to having an optimal DHA/EPA ratio.
The Journal of nutritional biochemistry